[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:pancreatic-adenocarcinoma":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":309,"states":324},"Pancreatic Adenocarcinoma",75,63,[8,16,23,30,36,42,48,55,61,67,73,79,85,91,97,103,109,115,121,127,133,139,145,151,157,162,168,174,180,185,191,197,202,208,214,220,226,232,238,244,250,256,262,268,274,280,286,292,297,303],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT07562152","Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma",[12],"Phase 3","RECRUITING","2026-08-26T02:15:57.572488Z","2026-07-05T05:32:16.684911Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT07259317","Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma",[20],"Phase 2","2026-08-26T02:18:12.612955Z","2026-07-05T05:32:16.672705Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":28,"content_modified":29},"NCT07671339","A Study of ELI-002 7P, With or Without Tislelizumab, in People With Pancreatic Cancer",[27],"Phase 1","2026-08-26T02:15:51.395565Z","2026-07-05T03:45:20.372123Z",{"nct_id":31,"title":32,"phases":33,"status":13,"updated_at":34,"content_modified":35},"NCT07621718","Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )",[12],"2026-08-26T02:17:38.215063Z","2026-06-04T01:30:07.905536Z",{"nct_id":37,"title":38,"phases":39,"status":13,"updated_at":40,"content_modified":41},"NCT07619313","AB801 in Combination With Chemotherapy and Immunotherapy for the Treatment of Patients With Borderline Resectable, Locally Advanced or Metastatic Cholangiocarcinoma or Pancreatic Cancer",[27],"2026-08-26T02:16:54.044282Z","2026-06-04T01:30:07.902796Z",{"nct_id":43,"title":44,"phases":45,"status":13,"updated_at":46,"content_modified":47},"NCT06698458","Alpha Radiation Emitters Device (DaRT) With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer",[],"2026-08-26T02:16:52.995882Z","2026-05-05T02:43:29.737034Z",{"nct_id":49,"title":50,"phases":51,"status":13,"updated_at":53,"content_modified":54},"NCT06483555","Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel",[52],"Phase 1\u002FPhase 2","2026-08-26T02:15:02.712396Z","2026-05-05T02:43:29.477558Z",{"nct_id":56,"title":57,"phases":58,"status":13,"updated_at":59,"content_modified":60},"NCT07189195","TR-002 for the Treatment of Advanced, Unresectable or Metastatic Solid Tumors and Unresectable or Metastatic, Refractory Pancreatic Adenocarcinoma",[27],"2026-08-26T02:19:08.862440Z","2026-05-05T02:43:29.385588Z",{"nct_id":62,"title":63,"phases":64,"status":13,"updated_at":65,"content_modified":66},"NCT04157127","Th-1 Dendritic Cell Immunotherapy Plus Standard Chemotherapy for Pancreatic Adenocarcinoma",[27],"2026-08-26T02:18:38.865010Z","2026-05-05T02:43:29.366404Z",{"nct_id":68,"title":69,"phases":70,"status":13,"updated_at":71,"content_modified":72},"NCT05624918","A Study of NovoTTF-200T(P) in Combination With Gemcitabine and Nab-Paclitaxel for Resectable Pancreatic Adenocarcinoma",[20],"2026-08-26T02:18:30.351130Z","2026-05-05T02:43:29.350710Z",{"nct_id":74,"title":75,"phases":76,"status":13,"updated_at":77,"content_modified":78},"NCT07481383","A First-in-Human Study to Evaluate Implantable Iontophoresis Chemotherapy Delivery Device With Gemcitabine Once Weekly or Twice Weekly in Participants With Pancreatic Cancer",[27],"2026-08-26T02:18:47.742071Z","2026-05-05T02:43:29.054207Z",{"nct_id":80,"title":81,"phases":82,"status":13,"updated_at":83,"content_modified":84},"NCT05688215","Zimberelimab and Quemliclustat in Combination With Chemotherapy for the Treatment of Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma",[52],"2026-08-26T02:15:00.557154Z","2026-05-05T02:43:29.023238Z",{"nct_id":86,"title":87,"phases":88,"status":13,"updated_at":89,"content_modified":90},"NCT06998940","Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations",[12],"2026-08-26T02:17:07.954622Z","2026-05-05T02:43:28.958937Z",{"nct_id":92,"title":93,"phases":94,"status":13,"updated_at":95,"content_modified":96},"NCT01954992","Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer",[12],"2026-08-26T02:19:16.454910Z","2026-05-05T02:43:28.901078Z",{"nct_id":98,"title":99,"phases":100,"status":13,"updated_at":101,"content_modified":102},"NCT05462496","Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer",[20],"2026-08-26T02:17:12.307088Z","2026-05-05T02:43:28.842661Z",{"nct_id":104,"title":105,"phases":106,"status":13,"updated_at":107,"content_modified":108},"NCT07076212","Evaluating NALIRIFOX vs Modified Gemcitabine, Nab-Paclitaxel and Cisplatin in Patients With Locally Advanced and Metastatic Pancreatic Adenocarcinoma",[20],"2026-08-26T02:19:11.399072Z","2026-05-05T02:43:28.654518Z",{"nct_id":110,"title":111,"phases":112,"status":13,"updated_at":113,"content_modified":114},"NCT07377045","Clinical Trial of OMTX705 in Combination With Gemcitabine\u002FNab-Paclitaxel and Tislelizumab in Patients With Advanced\u002FMetastatic Pancreatic Adenocarcinoma",[27],"2026-08-26T02:19:12.219640Z","2026-05-05T02:43:28.507368Z",{"nct_id":116,"title":117,"phases":118,"status":13,"updated_at":119,"content_modified":120},"NCT05776524","Study of Amplitude-Modulated Radiofrequency Electromagnetic Fields in Metastatic Pancreatic Cancer",[20],"2026-08-26T02:17:53.433613Z","2026-05-05T02:43:28.192732Z",{"nct_id":122,"title":123,"phases":124,"status":13,"updated_at":125,"content_modified":126},"NCT04926467","Chemotherapy + Anakinra in Patients With Pancreatic Adenocarcinoma (PDAC)",[20],"2026-08-26T02:17:22.949982Z","2026-05-05T02:43:28.188896Z",{"nct_id":128,"title":129,"phases":130,"status":13,"updated_at":131,"content_modified":132},"NCT06576115","Gemcitabine, Nab-paclitaxel Plus the TheraBionic P1 (an Amplitude-Modulated Radiofrequency Electromagnetic Fields) Device to Treat Metastatic Pancreatic Cancer",[20],"2026-08-26T02:19:01.741747Z","2026-05-05T02:43:28.114359Z",{"nct_id":134,"title":135,"phases":136,"status":13,"updated_at":137,"content_modified":138},"NCT07491445","Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma",[12],"2026-08-26T02:18:07.037408Z","2026-05-05T02:43:27.674571Z",{"nct_id":140,"title":141,"phases":142,"status":13,"updated_at":143,"content_modified":144},"NCT04605913","Nab-Paclitaxel + Cisplatin + Gemcitabine + TTF in pt. w\u002F Metastatic PAC",[52],"2026-08-26T02:18:04.640417Z","2026-05-05T02:43:27.639391Z",{"nct_id":146,"title":147,"phases":148,"status":13,"updated_at":149,"content_modified":150},"NCT07253662","Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Patients With Peritoneal Metastasis From Pancreatic Adenocarcinoma",[27],"2026-08-26T02:18:21.216897Z","2026-05-05T02:43:27.292758Z",{"nct_id":152,"title":153,"phases":154,"status":13,"updated_at":155,"content_modified":156},"NCT07126158","Stereotactic Body Radiotherapy Plus FAK and RAF\u002FMEK Inhibition in Advanced Pancreatic Adenocarcinoma",[20],"2026-08-26T02:16:48.735701Z","2026-05-05T02:43:27.292720Z",{"nct_id":158,"title":159,"phases":160,"status":13,"updated_at":59,"content_modified":161},"NCT07226856","BMS-986340 in Combination With Nivolumab, Gemcitabine and Nab-paclitaxel for the Treatment of Metastatic and Recurrent Pancreatic Adenocarcinoma",[20],"2026-05-05T02:43:26.964000Z",{"nct_id":163,"title":164,"phases":165,"status":13,"updated_at":166,"content_modified":167},"NCT06747845","Maintenance Niraparib Plus Ipilimumab in Patients With Metastatic Pancreatic Adenocarcinoma Whose Disease Has Not Progressed on Platinum-Based Chemotherapy",[20],"2026-08-26T02:17:54.420226Z","2026-05-05T02:43:26.960875Z",{"nct_id":169,"title":170,"phases":171,"status":13,"updated_at":172,"content_modified":173},"NCT06896188","9-ING-41 Combined With Retifanlimab, Plus Modified FOLFIRINOX for Patients With Advanced Pancreatic Adenocarcinoma (RiLEY)",[27],"2026-08-26T02:18:43.501109Z","2026-05-05T02:43:26.917884Z",{"nct_id":175,"title":176,"phases":177,"status":13,"updated_at":178,"content_modified":179},"NCT03080974","Immunotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma",[20],"2026-08-26T02:19:05.360997Z","2026-05-05T02:43:26.740235Z",{"nct_id":181,"title":182,"phases":183,"status":13,"updated_at":95,"content_modified":184},"NCT04172532","Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer",[52],"2026-05-05T02:35:31.778980Z",{"nct_id":186,"title":187,"phases":188,"status":13,"updated_at":189,"content_modified":190},"NCT07594067","TCR1188-ABC Cells in KRAS-mutated Cancers",[27],"2026-08-26T02:16:38.053590Z","2026-07-19T19:36:05.077181Z",{"nct_id":192,"title":193,"phases":194,"status":13,"updated_at":195,"content_modified":196},"NCT05365581","A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer",[27],"2026-08-26T02:17:42.501124Z","2026-07-05T05:32:16.805238Z",{"nct_id":198,"title":199,"phases":200,"status":13,"updated_at":59,"content_modified":201},"NCT06914128","A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors",[52],"2026-07-05T05:32:16.701684Z",{"nct_id":203,"title":204,"phases":205,"status":13,"updated_at":206,"content_modified":207},"NCT07277413","A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors",[27],"2026-08-26T02:16:01.910993Z","2026-07-05T05:32:16.679197Z",{"nct_id":209,"title":210,"phases":211,"status":13,"updated_at":212,"content_modified":213},"NCT07492680","A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and\u002For Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)",[20],"2026-08-26T02:17:47.813245Z","2026-06-16T05:54:07.939792Z",{"nct_id":215,"title":216,"phases":217,"status":13,"updated_at":218,"content_modified":219},"NCT06953089","DB-1311 in Combination With BNT327 or DB-1305 in Advanced\u002FMetastatic Solid Tumors",[20],"2026-08-26T02:19:18.331180Z","2026-06-16T05:54:07.929157Z",{"nct_id":221,"title":222,"phases":223,"status":13,"updated_at":224,"content_modified":225},"NCT04895709","A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors",[52],"2026-08-26T02:19:00.742020Z","2026-06-16T05:54:07.907527Z",{"nct_id":227,"title":228,"phases":229,"status":13,"updated_at":230,"content_modified":231},"NCT05000294","Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types",[52],"2026-08-26T02:17:17.791881Z","2026-06-06T00:48:49.531423Z",{"nct_id":233,"title":234,"phases":235,"status":13,"updated_at":236,"content_modified":237},"NCT07488676","A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors",[52],"2026-08-26T02:19:04.543908Z","2026-05-05T02:43:29.590211Z",{"nct_id":239,"title":240,"phases":241,"status":13,"updated_at":242,"content_modified":243},"NCT06756035","CT-95 in Advanced Cancers Associated With Mesothelin Expression",[27],"2026-08-26T02:16:07.529922Z","2026-05-05T02:43:28.867277Z",{"nct_id":245,"title":246,"phases":247,"status":13,"updated_at":248,"content_modified":249},"NCT05985655","Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors",[52],"2026-08-26T02:18:18.766496Z","2026-05-05T02:43:28.844240Z",{"nct_id":251,"title":252,"phases":253,"status":13,"updated_at":254,"content_modified":255},"NCT03740256","Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors",[27],"2026-08-26T02:16:17.877565Z","2026-05-05T02:43:28.644039Z",{"nct_id":257,"title":258,"phases":259,"status":13,"updated_at":260,"content_modified":261},"NCT07282912","Trial Comparing Standard of Care Therapy With and Without Sequential Cytoreductive Intervention for Patients With Metastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels",[20],"2026-08-26T02:19:29.119921Z","2026-05-05T02:43:28.285786Z",{"nct_id":263,"title":264,"phases":265,"status":13,"updated_at":266,"content_modified":267},"NCT04361708","Safety of Combining Irinotecan With 5-FU, Leucovorin\u002FFolinic Acid, Oxaliplatin, and Docetaxel Chemotherapies",[27],"2026-08-26T02:18:37.277498Z","2026-05-05T02:43:27.322062Z",{"nct_id":269,"title":270,"phases":271,"status":13,"updated_at":272,"content_modified":273},"NCT06399757","A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors",[52],"2026-08-03T03:48:46.663572Z","2026-05-05T02:43:27.110534Z",{"nct_id":275,"title":276,"phases":277,"status":13,"updated_at":278,"content_modified":279},"NCT05245500","Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion",[27],"2026-08-26T02:18:27.904411Z","2026-05-05T02:43:26.709142Z",{"nct_id":281,"title":282,"phases":283,"status":13,"updated_at":284,"content_modified":285},"NCT05841563","Clinical Trial of PM54 in Advanced Solid Tumors Patients.",[27],"2026-08-26T02:15:18.897219Z","2026-05-05T02:43:26.706220Z",{"nct_id":287,"title":288,"phases":289,"status":13,"updated_at":290,"content_modified":291},"NCT06778863","A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation",[27],"2026-08-26T02:15:47.754948Z","2026-05-05T02:43:26.672516Z",{"nct_id":293,"title":294,"phases":295,"status":13,"updated_at":95,"content_modified":296},"NCT04389632","A Study of Sigvotatug Vedotin in Advanced Solid Tumors",[27],"2026-05-05T02:35:31.860308Z",{"nct_id":298,"title":299,"phases":300,"status":13,"updated_at":301,"content_modified":302},"NCT05482516","Evaluating Novel Therapies in ctDNA Positive GI Cancers",[12],"2026-08-26T02:18:55.570428Z","2026-04-29T02:57:57.077131Z",{"nct_id":304,"title":305,"phases":306,"status":13,"updated_at":307,"content_modified":308},"NCT06861088","The Effect of Kinisoquin™ on Thromboembolic Events in Patients With Metastatic or Locally Advanced Pancreatic Cancer",[12],"2026-08-26T02:15:33.331531Z","2026-05-05T02:43:29.296455Z",[310,314,318,321],{"biomarker":311,"count":312,"slug":313},"MTAP Gene",5,"mtap-gene",{"biomarker":315,"count":316,"slug":317},"Circulating Tumor-Derived DNA Negative",3,"circulating-tumor-derived-dna-negative",{"biomarker":319,"count":316,"slug":320},"GTPase KRas","gtpase-kras",{"biomarker":322,"count":316,"slug":323},"Programmed Cell Death 1 Ligand 1","programmed-cell-death-1-ligand-1",[325,329,333,337,341,345,348,352,355,359,362,365,369,372,375,379,382,385,389,392,395,399,403,406],{"state":326,"count":327,"slug":328},"California",29,"california",{"state":330,"count":331,"slug":332},"Texas",27,"texas",{"state":334,"count":335,"slug":336},"New York",23,"new-york",{"state":338,"count":339,"slug":340},"Florida",22,"florida",{"state":342,"count":343,"slug":344},"Michigan",15,"michigan",{"state":346,"count":343,"slug":347},"Pennsylvania","pennsylvania",{"state":349,"count":350,"slug":351},"New Jersey",14,"new-jersey",{"state":353,"count":350,"slug":354},"Ohio","ohio",{"state":356,"count":357,"slug":358},"Illinois",13,"illinois",{"state":360,"count":357,"slug":361},"North Carolina","north-carolina",{"state":363,"count":357,"slug":364},"Tennessee","tennessee",{"state":366,"count":367,"slug":368},"Arizona",11,"arizona",{"state":370,"count":367,"slug":371},"Washington","washington",{"state":373,"count":367,"slug":374},"Wisconsin","wisconsin",{"state":376,"count":377,"slug":378},"Colorado",10,"colorado",{"state":380,"count":377,"slug":381},"Massachusetts","massachusetts",{"state":383,"count":377,"slug":384},"Virginia","virginia",{"state":386,"count":387,"slug":388},"Georgia",9,"georgia",{"state":390,"count":387,"slug":391},"Maryland","maryland",{"state":393,"count":387,"slug":394},"Minnesota","minnesota",{"state":396,"count":397,"slug":398},"Utah",7,"utah",{"state":400,"count":401,"slug":402},"Indiana",6,"indiana",{"state":404,"count":401,"slug":405},"Kentucky","kentucky",{"state":407,"count":401,"slug":408},"Missouri","missouri"]